The above-mentioned guideline by Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, Yogev Y (J Clin Endo Metab. 2013; 98(11): 4227-4249; doi: 10.1210/jc.2013-2465) was retired on May 1, 2022.
Endocrine Society guidelines can be retired for any of the following reasons: the guideline as a whole is sufficiently out of date that it is no longer relevant to clinical practice; one or more of the guideline recommendations contain important inaccuracies or omissions that, if followed precisely, could lead to substandard patient care or potential harm; or the guideline has been replaced by a more recent publication.
doi: 10.1210/jc.2013-2465